Page 125 - 78_02

SESIÓN
CIENTÍFICA
PREMIO
NOBEL
2011….

Conseguir
vacunas
efectivas
frente
a
determinados
procesos
como
el

cáncer,
implica
poder
modular
el
sistema
inmune
adaptativo
de
modo
que
sea
más

inmunogénico
y
menos
tolerogénico.
Igualmente,
se
está
estudiando
el
posible
uso

de
poblaciones
de
Células
Dendríticas
con
potencial
tolerogénico,
es
decir,
capaces

de
mantener
inactivo
al
sistema
inmune,
para
combatir
procesos
donde
el
sistema

inmune
se
activa
de
forma
no
deseada,
dando
lugar
a
una
patología
como
es
el
caso

de
las
enfermedades
autoinmunes,
alergias
y
trasplantes
de
órganos
(50,
51).

REFERENCIAS

1.

Janeway,
C.;
Evolution
and
revolution
in
immunology.
Cold
Spring
Harbor
Symp
Quant
Biol.

1989,
54,
1-­-13.

2.
Matzinger,
P.;
Tolerance,
danger
and
the
extended
family.
Annu
Rev
Immunol.
1994,
12,
991-­-
1045.

3.
Anderson,
K.V.;
Bokla,
L.;
Nüsslein-­-Volhard,
C.;
Establishment
of
dorsal-­-ventral
polarity
in
the

Drosophila
embryo:
the
induction
of
polarity
by
the
Toll
gene
product.
Cell.
1985,
42,
791-­-798.

4.
Steiner,
H.;
Hultmark,
D.;
Engström,
A.;
Bennich,
H.;
Boman,
H.G.;
Sequence
and
specificity
of
two

antibacterial
proteins
involved
in
insect
immunity.
Nature.
1981,
292,
246-­-248.

5.
Lemaitre,
B.;
Nicolas,
E.;
Michaut,
L.;
Reichhart,
J.M.;
Hoffmann,
J.A.;
The
dorsoventral
regulatory

gene
cassette
spätzle/Toll/cactus
controls
the
potent
antifungal
response
in
Drosophila
adults.

Cell.
1996,
86;
973-­-983.

6.
Hoffmann,
J.A.;
Reichhart,
J.M.
Drosophila
innate
immunity:
an
evolutionary
perspective.

Nat

Immunol.
2002,
3,
121-­-126.

7.
Medzhitov,
R.;
Preston-­-Hurlburt,
P.;
Janeway,
C.A.
Jr.
A
human
homologue
of
the
Drosophila
Toll

protein
signals
activation
of
adaptive
immunity.
Nature.
1997,
388,
394-­-397.

8.
Hoffmann,
J,A;
Kafatos,
F.C.;
Janeway,
C.A.;
Ezekowitz,
R.A.;
Phylogenetic
perspectives
in
innate

immunity.

Science.
1999,
284,
1313-­-1318.

9.
Gay,
N.J.;
Keith,
F.J.;
Drosophila
Toll
and
IL-­-1
receptor.
Nature.
1991,
351,
355-­-356.

10.
Poltorak,
A.;
He,
X.;
Smirnova,
I.;
Liu,
M.Y.;
Van
Huffel,
C.;
Du,
X.;
Birdwell,
D.;
Alejos,
E.;
Silva,
M.;

Galanos,
C.;
Freudenberg,
M.;
Ricciardi-­-Castagnoli,
P.;
Layton,
B.;
Beutler,
B.;.
Defective
LPS

signaling
in
C3H/HeJ
and
C57BL/10ScCr
mice:
mutations
in
Tlr4
gene.

Science,
1998,
282,
2085-­-
2088.

11.
Beutler,
B.A.;
TLRs
and
innate
immunity.

Blood.
2009,
13,
1399-­-1407.

12.
da
Silva
Correia,
J.;
Soldau,
K.;
Christen,
U.;
Tobias,
P.S.;
Ulevitch,
R.J.;
Lipopolysaccharide
is
in

close
proximity
to
each
of
the
proteins
in
its
membrane
receptor
complex.
transfer
from
CD14
to

TLR4
and
MD-­-2.
J
Biol
Chem.
2001,

276,
21129-­-21135.

13
Heguy,
A.;
Baldari,
C.T.;
Macchia,
G.;
Telford,
J.L.;
Melli,
M.;
Amino
acids
conserved
in

interleukin-­-1
receptors
(IL-­-1Rs)
and
the
Drosophila
toll
protein
are
essential
for
IL-­-1R
signal

transduction.
J
Biol
Chem.
1992,
267,
2605-­-2609.

14.
Muzio,
M.;
Ni,
J.;
Feng,
P.;
Dixit,
V.M.;
IRAK
(Pelle)
family
member
IRAK-­-2
and
MyD88
as

proximal
mediators
of
IL-­-1
signaling.
Science.
1997,
278,
1612-­-1615.

15.
Muzio,
M.;
Natoli,
G.;
Saccani,
S.;
Levrero,
M.;
Mantovani,
A.;
The
human
toll
signaling
pathway:

divergence
of
nuclear
factor
kappaB
and
JNK/SAPK
activation
upstream
of
tumor
necrosis
factor

receptor-­-associated
factor
6
(TRAF6).
J
Exp
Med.
1998,
187,
2097-­-2101.

16.
Takeuchi,
O.;
Akira,
S.;
Pattern
recognition
receptors
and
inflammation.
Cell.
2010,
140,
805-­-
820.

261